Alnylam Pharmaceuticals
ALNY
#582
Rank
ยฃ26.50 B
Marketcap
ยฃ204.77
Share price
-1.39%
Change (1 day)
68.62%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company